Neurodegenerative Disease Market

Future Market Insights

Key Insight

The neurodegenerative disease market is projected to grow from USD 55.6 billion in 2025 to USD 109.5 billion by 2035, at a CAGR of 6.9%. Dopamine Inhibitors will dominate with a 44.1% market share, while alzheimer's disease will lead the disease indication segment with a 46.3% share.

October 07, 2025

Anurag Sharma

250 Pages

Cite this Report

Neurodegenerative Disease Market

https://www.futuremarketinsights.com/reports/neurodegenerative-disease-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

L'Oréal

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Neurodegenerative Disease Market

Key Players

Similar Industry Reports